Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
439.2 INR | -0.88% | -0.61% | +2.09% |
08:41am | Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024 | MT |
Apr. 15 | Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company | MT |
Sales 2024 * | 50.57B 606M | Sales 2025 * | 58.82B 705M | Capitalization | 239B 2.86B |
---|---|---|---|---|---|
Net income 2024 * | 1.95B 23.35M | Net income 2025 * | 4.31B 51.65M | EV / Sales 2024 * | 5.09 x |
Net Debt 2024 * | 18.41B 221M | Net Debt 2025 * | 18.61B 223M | EV / Sales 2025 * | 4.38 x |
P/E ratio 2024 * |
124
x | P/E ratio 2025 * |
52
x | Employees | 5,753 |
Yield 2024 * |
0.3% | Yield 2025 * |
0.37% | Free-Float | 65.41% |
Latest transcript on Laurus Labs Limited
1 day | -0.89% | ||
1 week | -0.61% | ||
Current month | +11.94% | ||
1 month | +10.49% | ||
3 months | +5.82% | ||
6 months | +10.06% | ||
Current year | +2.09% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 63 | 05-09-18 | |
Director of Finance/CFO | - | 06-11-29 | |
S. Srinivasa Rao
COO | Chief Operating Officer | - | 08-04-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 63 | 05-09-18 | |
Chairman | 83 | 17-05-23 | |
Director/Board Member | 68 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 6 M€ | +6.07% | - | |
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 439.2 | -0.88% | 1 029 525 |
24-04-16 | 443.2 | +3.07% | 2,633,516 |
24-04-15 | 430 | -2.70% | 4,040,007 |
24-04-12 | 441.9 | -3.83% | 4,964,802 |
24-04-10 | 459.5 | +1.20% | 4,113,449 |
Delayed Quote NSE India S.E., April 18, 2024 at 04:15 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.09% | 2.85B | |
+28.79% | 676B | |
+25.17% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.49% | 210B | |
-0.28% | 204B | |
-9.33% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- LAURUSLABS Stock